John A. Doukas

7.7k total citations · 1 hit paper
165 papers, 5.4k citations indexed

About

John A. Doukas is a scholar working on Accounting, Finance and Economics and Econometrics. According to data from OpenAlex, John A. Doukas has authored 165 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Accounting, 99 papers in Finance and 52 papers in Economics and Econometrics. Recurrent topics in John A. Doukas's work include Corporate Finance and Governance (84 papers), Financial Markets and Investment Strategies (78 papers) and Auditing, Earnings Management, Governance (47 papers). John A. Doukas is often cited by papers focused on Corporate Finance and Governance (84 papers), Financial Markets and Investment Strategies (78 papers) and Auditing, Earnings Management, Governance (47 papers). John A. Doukas collaborates with scholars based in United States, United Kingdom and Ghana. John A. Doukas's co-authors include Bala Arshanapalli, Christos Pantzalis, Chansog Kim, Constantinos Antoniou, Avanidhar Subrahmanyam, Nickolaos G. Travlos, Dimitris Petmezas, Larry H.P. Lang, Lorne N. Switzer and Halit Gönenç and has published in prestigious journals such as The Journal of Finance, Management Science and The FASEB Journal.

In The Last Decade

John A. Doukas

158 papers receiving 5.0k citations

Hit Papers

Cognitive Dissonance, Sentiment, and Momentum 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Doukas United States 38 3.0k 2.7k 2.1k 1.1k 708 165 5.4k
David E. Weinstein United States 37 1.1k 0.4× 1.4k 0.5× 3.6k 1.7× 1.4k 1.2× 3.2k 4.5× 104 7.2k
Moshe Kim Israel 17 705 0.2× 879 0.3× 643 0.3× 500 0.4× 189 0.3× 56 2.4k
Paolo Angelini United States 42 982 0.3× 2.4k 0.9× 2.3k 1.1× 195 0.2× 1.4k 1.9× 179 7.8k
Robert Hudson United Kingdom 34 479 0.2× 1.1k 0.4× 1.2k 0.6× 168 0.2× 182 0.3× 164 4.2k
Peter Wright United States 39 2.3k 0.8× 549 0.2× 1.8k 0.8× 2.5k 2.2× 978 1.4× 151 6.2k
David W. Mullins United States 34 1.9k 0.6× 1.5k 0.6× 501 0.2× 760 0.7× 44 0.1× 90 4.9k
Jeffrey F. Jaffe United States 20 2.9k 1.0× 2.3k 0.8× 1.4k 0.7× 927 0.8× 399 0.6× 44 4.1k
Fred H. Allen United States 32 2.4k 0.8× 965 0.4× 1.2k 0.6× 822 0.7× 167 0.2× 138 6.3k
Edward M. Miller United States 23 2.0k 0.7× 2.8k 1.0× 1.6k 0.8× 476 0.4× 345 0.5× 113 4.3k

Countries citing papers authored by John A. Doukas

Since Specialization
Citations

This map shows the geographic impact of John A. Doukas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Doukas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Doukas more than expected).

Fields of papers citing papers by John A. Doukas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Doukas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Doukas. The network helps show where John A. Doukas may publish in the future.

Co-authorship network of co-authors of John A. Doukas

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Doukas. A scholar is included among the top collaborators of John A. Doukas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Doukas. John A. Doukas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doukas, John A., et al.. (2025). The Role of Intangible Assets in Shaping Firm Value. European Financial Management. 31(4). 1325–1353. 1 indexed citations
2.
Chen, Chen & John A. Doukas. (2024). Do Stock Price Informativeness and Managerial Attributes Facilitate M&A Success?. RePEc: Research Papers in Economics. 4(3). 203–262. 1 indexed citations
3.
Doukas, John A., et al.. (2023). When does CSR payoff?. European Financial Management. 30(4). 2242–2304. 2 indexed citations
4.
Doukas, John A., et al.. (2023). CEO Dismissal Risk and Risky Corporate Investments. SSRN Electronic Journal.
5.
Doukas, John A., et al.. (2022). Are CEOs to Blame for Corporate Failure? Evidence from Chapter 11 Filings. ODU Digital Commons (Old Dominion University). 2(1). 1–63. 8 indexed citations
6.
Doukas, John A., et al.. (2022). The Effect of Corporate Investment Efficiency on Cross-Border M&As. RePEc: Research Papers in Economics. 2(2). 235–294. 17 indexed citations
7.
Doukas, John A., et al.. (2021). Managerial Ability, Corporate Social Culture, and M&As. SSRN Electronic Journal. 1 indexed citations
8.
Doukas, John A., et al.. (2017). CEO personal investment decisions and firm risk. European Financial Management. 23(5). 920–950. 26 indexed citations
9.
Raviprakash, Kanakatte, Thomas Luke, John A. Doukas, et al.. (2012). A dengue DNA vaccine formulated with Vaxfectin®is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits. Human Vaccines & Immunotherapeutics. 8(12). 1764–1768. 15 indexed citations
10.
Hartikka, Jukka, Vesselina Bozoukova, Jane Morrow, et al.. (2012). Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus. Human Vaccines & Immunotherapeutics. 8(11). 1595–1606. 11 indexed citations
11.
Ye, Ming, Qun Wei, John A. Doukas, et al.. (2009). RAPID DEVELOPMENT OF A VAXFECTIN®-ADJUVANTED DNA VACCINE ENCODING PANDEMIC SWINE-ORIGIN INFLUENZA A VIRUS (H1N1) HEMAGGLUTININ. 4(1). 45–55. 1 indexed citations
12.
Doukas, John A. & Lorne N. Switzer. (2008). Economies of Scale and Scope in Canadian Branch Banking. Journal of International Financial Markets Institutions and Money. 4 indexed citations
13.
Horvath, Keith J., et al.. (2005). Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach. Journal of Thoracic and Cardiovascular Surgery. 129(5). 1071–1077. 14 indexed citations
14.
Doukas, John A., et al.. (2004). Excess Cash Flows and Diversification Discount. Financial Management. 33(2). 71. 22 indexed citations
15.
Song, Antonius, John A. Doukas, Barbara A. Sosnowski, et al.. (2003). Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates. Molecular Therapy. 8(1). 99–107. 89 indexed citations
16.
Horvath, Keith J., et al.. (2002). Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging. The Annals of Thoracic Surgery. 74(2). 481–487. 37 indexed citations
17.
Doukas, John A., Kate Blease, Chenglie Ma, et al.. (2002). Delivery of FGF Genes to Wound Repair Cells Enhances Arteriogenesis and Myogenesis in Skeletal Muscle. Molecular Therapy. 5(5). 517–527. 90 indexed citations
18.
Hoganson, Diana K., Barbara A. Sosnowski, Glenn F. Pierce, & John A. Doukas. (2001). Uptake of Adenoviral Vectors via Fibroblast Growth Factor Receptors Involves Intracellular Pathways That Differ from the Targeting Ligand. Molecular Therapy. 3(1). 105–112. 16 indexed citations
19.
Chandler, Lois A., Chenglie Ma, Ana María Gonzalez, et al.. (2000). Matrix‐enabled gene transfer for cutaneous wound repair. Wound Repair and Regeneration. 8(6). 473–479. 81 indexed citations
20.
Choi, Jongmoo Jay & John A. Doukas. (1998). Emerging capital markets : financial and investment issues. ODU Digital Commons (Old Dominion University). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026